Cargando…
Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation
BACKGROUND: Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving valganciclovir when viral load exceeds a defined value. We hypothesised that such pre-emptive therapy should occur earlier than the standard 3000 genomes/ml (2520 IU/ml) when a seropositive donor t...
Autores principales: | Lumley, Sheila, Green, Cameron, Rafferty, Hannah, Smith, Colette, Harber, Mark, O’Beirne, James, Jones, Gareth, Thorburn, Douglas, Marshall, Aileen, Shah, Tina, Zuhair, Mohamed, Rothwell, Emily, Atabani, Sowsan, Haque, Tanzina, Griffiths, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347177/ https://www.ncbi.nlm.nih.gov/pubmed/30682032 http://dx.doi.org/10.1371/journal.pone.0210420 |
Ejemplares similares
-
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy
por: Griffiths, Paul D., et al.
Publicado: (2016) -
Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy
por: Griffiths, Paul D., et al.
Publicado: (2017) -
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
por: Griffiths, Paul D, et al.
Publicado: (2011) -
Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
por: Rafferty, Hannah, et al.
Publicado: (2022) -
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
por: Atabani, S F, et al.
Publicado: (2012)